A. Martini, A. Ravelli, T. Avcin, M. W. Beresford, R. Burgos-vargas et al., Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus, J. Rheumatol, vol.46, pp.190-197, 2019.

G. Giancane, A. Alongi, and A. Ravelli, Update on the pathogenesis and treatment of juvenile idiopathic arthritis, Curr. Opin. Rheumatol, vol.29, pp.523-529, 2017.

J. G. Harris, E. A. Kessler, and J. W. Verbsky, Update on the Treatment of Juvenile Idiopathic Arthritis, Curr. Allergy Asthma Rep, vol.13, pp.337-346, 2013.

J. S. Smolen, D. Aletaha, and I. B. Mcinnes, Rheumatoid arthritis, Lancet, vol.388, pp.2023-2038, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01557559

I. Duroux-richard, C. Jorgensen, and F. Apparailly, What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum, vol.64, pp.11-20, 2012.

T. Nakasa, S. Miyaki, A. Okubo, M. Hashimoto, K. Nishida et al., Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, vol.58, pp.1284-1292, 2008.

S. Ono, S. Lam, M. Nagahara, and D. S. Hoon, Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays, J. Clin. Med, vol.4, pp.1890-1907, 2015.

J. Stanczyk, D. M. Pedrioli, F. Brentano, O. Sanchez-pernaute, C. Kolling et al., Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, vol.58, pp.1001-1009, 2008.

R. Vicente, D. Noël, Y. Pers, F. Apparailly, and C. Jorgensen, Deregulation and therapeutic potential of microRNAs in arthritic diseases, Nat. Rev. Rheumatol, vol.12, pp.211-220, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01834238

D. Li, M. Duan, Y. Feng, L. Geng, X. Li et al., MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA, Mol. Immunol, vol.77, pp.205-212, 2016.

G. S. Schulert, N. Fall, J. B. Harley, N. Shen, D. J. Lovell et al., Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes, Arthritis Rheumatol, vol.68, pp.2300-2313, 2016.

J. Sun, M. Feng, F. Wu, X. Ma, J. Lu et al., Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis, J. Rheumatol, vol.43, pp.1607-1614, 2016.

Y. Kamiya, J. Kawada, Y. Kawano, Y. Torii, S. Kawabe et al., Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis, Clin. Rheumatol, vol.34, pp.1705-1712, 2015.

X. Ma, F. Wu, L. Xin, G. Su, F. He et al., Differential plasma microRNAs expression in juvenile idiopathic arthritis, Mod. Rheumatol, vol.26, pp.1-9, 2015.

S. Singh, G. Rai, and A. Aggarwal, Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis, Rheumatol. Int, vol.34, pp.1395-1400, 2014.

N. I. Montgomery and H. R. Epps, Pediatric Septic Arthritis, Orthop. Clin. N. Am, vol.48, pp.209-216, 2017.

A. M. El-sayed, Treatment of early septic arthritis of the hip in children: Comparison of results of open arthrotomy versus arthroscopic drainage, J. Child. Orthop, vol.2, pp.229-237, 2008.

G. Dubnov-raz, O. Scheuerman, G. Chodick, Y. Finkelstein, Z. Samra et al., Invasive Kingella kingae infections in children: Clinical and laboratory characteristics, Pediatrics, vol.122, pp.1305-1309, 2008.

M. Martinot, C. Sordet, M. Soubrier, X. Puéchal, A. Saraux et al., Diagnostic value of serum and synovial procalcitonin in acute arthritis: A prospective study of 42 patients, Clin. Exp. Rheumatol, vol.23, pp.303-310, 2005.

T. Honda, T. Uehara, G. Matsumoto, S. Arai, and M. Sugano, Neutrophil left shift and white blood cell count as markers of bacterial infection, Clin. Chim. Acta, vol.457, pp.46-53, 2016.

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments, Clin. Chem, vol.55, pp.611-622, 2009.

S. Tyanova, T. Temu, P. Sinitcyn, A. Carlson, M. Y. Hein et al., The Perseus computational platform for comprehensive analysis of (prote)omics data, Nat. Methods, vol.13, pp.731-740, 2016.

D. Faraggi and A. Kramar, Methodological issues associated with tumor marker development: Biostatistical aspects, Urol. Oncol, vol.5, pp.211-213, 2000.

A. Kramar, D. Faraggi, A. Fortuné, and B. Reiser, mROC: A computer program for combining tumour markers in predicting disease states, Comput. Methods Programs Biomed, vol.66, pp.199-207, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00123024

K. Murata, H. Yoshitomi, S. Tanida, M. Ishikawa, K. Nishitani et al., Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res. Ther, p.86, 2010.

C. C. Pritchard, E. Kroh, B. Wood, J. D. Arroyo, K. J. Dougherty et al., Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies, Cancer Prev. Res, vol.5, pp.492-497, 2012.

M. Monleau, S. Bonnel, T. Gostan, D. Blanchard, V. Courgnaud et al., Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells, BMC Genom, p.395, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02191582

Y. Kim, J. Yeo, B. Kim, M. Ha, and V. N. Kim, Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells, Mol. Cell, vol.46, pp.893-895, 2012.

J. Rice, H. Roberts, J. Burton, J. Pan, V. States et al., Assay reproducibility in clinical studies of plasma miRNA, PLoS ONE, vol.10, 2015.

P. Mestdagh, N. Hartmann, L. Baeriswyl, D. Andreasen, N. Bernard et al., Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study, Nat. Methods, vol.11, pp.809-815, 2014.

J. Chen, G. Papp, S. Póliska, K. Szabó, T. Tarr et al., MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome, PLoS ONE, vol.12, p.174585, 2017.

R. Hezova, O. Slaby, P. Faltejskova, Z. Mikulkova, I. Buresova et al., microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients, Cell. Immunol, vol.260, pp.70-74, 2010.

T. Niimoto, T. Nakasa, M. Ishikawa, A. Okuhara, B. Izumi et al., MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet. Disord, p.209, 2010.

K. M. Pauley and S. Cha, miRNA-146a in rheumatoid arthritis: A new therapeutic strategy, Immunotherapy, vol.3, pp.829-831, 2011.

A. V. Churov, E. K. Oleinik, and M. Knip, MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential, Autoimmun. Rev, vol.14, pp.1029-1037, 2015.

A. Lenert and D. W. Fardo, Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing, Clin. Exp. Rheumatol, vol.35, pp.586-592, 2017.

D. Malik, A. Sharma, A. Raina, and D. Kaul, Deregulated Blood Cellular miR-2909 RNomics Observed in Rheumatoid Arthritis Subjects, Arch. Med, vol.7, pp.1-6, 2015.

D. Kaul, M. Sasikala, and A. Raina, Regulatory role of miR-2909 in cell-mediated immune response, Cell Biochem. Funct, vol.30, pp.500-504, 2012.

K. D. Taganov, M. P. Boldin, K. Chang, and D. Baltimore, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl. Acad. Sci, vol.103, pp.12481-12486, 2006.

I. Faraoni, F. R. Antonetti, and J. Cardone, Bonmassar, E. miR-155 gene: A typical multifunctional microRNA, Biochim. Biophys. Acta, vol.1792, pp.497-505, 2009.

L. Wang, Y. Qin, L. Tong, S. Wu, Q. Wang et al., MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region, Antivir. Res, vol.93, pp.270-279, 2012.

C. Vasilescu, S. Rossi, M. Shimizu, S. Tudor, A. Veronese et al., MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis, PLoS ONE, vol.4, p.7405, 2009.

Q. Li, Y. Fang, P. Zhu, C. Ren, H. Chen et al., Burkholderia pseudomallei survival in lung epithelial cells benefits from miRNA-mediated suppression of ATG10, Autophagy, vol.11, pp.1293-1307, 2015.

S. C. Wong, R. Dobie, M. A. Altowati, G. A. Werther, C. Farquharson et al., Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children with Chronic. Dir, Endocr. Rev, vol.37, pp.62-110, 2016.

V. Wiegering, H. J. Girschick, and H. Morbach, B-cell pathology in juvenile idiopathic arthritis, p.759868, 2010.

M. G. Barnes, A. A. Grom, S. D. Thompson, T. A. Griffin, P. Pavlidis et al., Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis, Arthritis Rheum, vol.60, pp.2102-2112, 2009.

B. Koca, S. Sahin, A. Adrovic, K. Barut, and O. Kasapcopur, Cardiac involvement in juvenile idiopathic arthritis, Rheumatol. Int, vol.37, pp.137-142, 2017.

J. Nicolau, T. Lequerré, H. Bacquet, and O. Vittecoq, Rheumatoid arthritis, insulin resistance, and diabetes, Jt. Bone Spine, vol.84, pp.411-416, 2017.

C. Aupiais, R. Basmaci, B. Ilharreborde, A. Blachier, M. Desmarest et al., Arthritis in children: Comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis, vol.102, pp.316-322, 2017.

R. Basmaci, B. Ilharreborde, S. Bonacorsi, M. Kahil, C. Mallet et al., Septic arthritis in children with normal initial C-reactive protein: Clinical and biological features, Arch. Pediatr, vol.21, pp.1195-1199, 2014.